scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41556-020-0522-Z |
P698 | PubMed publication ID | 32483387 |
P50 | author | Xin-Yuan Guan | Q39845550 |
Song Gao | Q43087554 | ||
Xintao Shuai | Q55459907 | ||
Jianhua Sui | Q56435627 | ||
Yi-Xin Zeng | Q68692568 | ||
Tiebang Kang | Q80427472 | ||
Jian Chen | Q90384625 | ||
Junqiang Yin | Q92641764 | ||
Li Zhong | Q93037850 | ||
Dan Liao | Q96128093 | ||
Cuiling Zeng | Q96128095 | ||
Xingchuan Huang | Q96128098 | ||
Jinna Chen | Q96128102 | ||
Jing-Nan Shen | Q96128106 | ||
P2093 | author name string | Hong Zhang | |
Xin Wang | |||
Wuguo Deng | |||
Ruhua Zhang | |||
P2860 | cites work | Structural basis of family-wide Rab GTPase recognition by rabenosyn-5 | Q24309272 |
Massive genomic rearrangement acquired in a single catastrophic event during cancer development | Q24631164 | ||
STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
RHO-GTPases and cancer | Q29616099 | ||
Transforming fusions of FGFR and TACC genes in human glioblastoma | Q30540467 | ||
Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers | Q30990555 | ||
Discovering and understanding oncogenic gene fusions through data intensive computational approaches | Q31083417 | ||
Bone cancers | Q33278496 | ||
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program | Q33406382 | ||
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs | Q33897492 | ||
Splice variants of SmgGDS control small GTPase prenylation and membrane localization | Q34284968 | ||
Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. | Q34413741 | ||
Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma. | Q34637826 | ||
SmgGDS is a guanine nucleotide exchange factor that specifically activates RhoA and RhoC. | Q34752099 | ||
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma | Q34793401 | ||
Tissue-penetrating delivery of compounds and nanoparticles into tumors | Q35016106 | ||
Mechanisms of sarcoma development | Q35210018 | ||
Sambamba: fast processing of NGS alignment formats. | Q35564265 | ||
Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations | Q36905633 | ||
WWP2 is an E3 ubiquitin ligase for PTEN. | Q37588182 | ||
Translational biology of osteosarcoma | Q38260633 | ||
The emerging complexity of gene fusions in cancer | Q38496502 | ||
Structure-based analysis of the guanine nucleotide exchange factor SmgGDS reveals armadillo-repeat motifs and key regions for activity and GTPase binding | Q38718476 | ||
Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway. | Q38850159 | ||
MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. | Q39892019 | ||
Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases | Q40009092 | ||
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer | Q40099013 | ||
Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines | Q40144770 | ||
Bone cancer incidence by morphological subtype: a global assessment | Q40857727 | ||
Molecular Principles of Gene Fusion Mediated Rewiring of Protein Interaction Networks in Cancer | Q40969365 | ||
Chromoplexy: a new category of complex rearrangements in the cancer genome | Q41584698 | ||
Inherited germline ATRX mutation in two brothers with ATR-X syndrome and osteosarcoma. | Q52100135 | ||
A novel mutation in ATRX associated with intellectual disability, syndromic features, and osteosarcoma. | Q53383563 | ||
Determination of GTP loading on Rho | Q57446974 | ||
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors | Q60355290 | ||
Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma | Q74610152 | ||
Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer | Q80370519 | ||
WHO Classification of Soft Tissue and Bone, fourth edition: summary and commentary | Q87249074 | ||
Protective effect of aspirin associated with SNP | Q87403666 | ||
SmgGDS-607 Regulation of RhoA GTPase Prenylation Is Nucleotide-Dependent | Q89234760 | ||
GEF mechanism revealed by the structure of SmgGDS-558 and farnesylated RhoA complex and its implication for a chaperone mechanism | Q91321915 | ||
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials | Q91981735 | ||
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials | Q91981779 | ||
The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases | Q92732835 | ||
Targeting chromatin complexes in fusion protein-driven malignancies | Q92955229 | ||
P2507 | corrigendum / erratum | Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma | Q96302760 |
P577 | publication date | 2020-06-01 | |
P1433 | published in | Nature Cell Biology | Q1574111 |
P1476 | title | Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma |
Q98665060 | Rab22a-NeoF1: a promising target for osteosarcoma patients with lung metastasis | cites work | P2860 |